The Inaugural MedFemTech Congress
Palais des Congres, Paris, France | May 2025
Promoting emerging medical solutions for women to improve diagnostics and treatment
Founding Partners
Knowledge Partner
MedFemTech Congress
The inaugural MedFemTech Congress will connect and engage key players in the female medical technology sector, launching a global community of medical professionals, tech visionaries, innovators, investors and other experts from across the health care ecosystem – representing doctors, hospitals, clinics, academia, venture capital firms and technology solution companies.
The overall fem-tech market was valued at $18.7B in 2019 and is projected to reach $60.1B by 2027, with a CAGR of over 15.6%. The industry value remains underestimated.
Over 1,500 companies have been classified as med-fem-tech, categorized into 14 subsectors and 8 aggregated subsectors by application. Of the total market, pregnancy is the largest one.
The inaugural congress will offer a 2-day scientific program focusing on the main medical challenges facing women, primarily highlighting the following topics:
- Maternal health, prenatal care and breastfeeding
- Menstrual health
- Pelvic, sexual organ and other gynecological cancers
- Reproductive health, assisted reproduction technologies
- Endometriosis, pelvic floor and sexual health
- Women’s cancer: breast cancer and reconstruction, ovarian cancer and cervical cancer
- Menopause and peri- and post-menopausal symptoms
- Contraception: oral contraceptives and IUDs
- Gynecological infections: bacterial vaginosis, HPV and sexually transmitted diseases
- Longevity
- Diagnostics
- Artificial intelligence (AI) for women’s health
- Advanced medicine for women
Each topic will be headlined by a medical presentation and followed by 5-10 brief “lightning talks” by start-ups focusing on their relevant innovation.
The congress will host 50-100 exhibitors with a focus on start-up companies and will offer unique networking opportunities and individual meetings among investors, industry professionals and start-ups.
Forbes “spotlight” articles will provide global exposure for top selected start-ups presented throughout the congress.
We hope to see you in Paris in May 2023 for this innovative event!
MedFemTech Mobile App
To get the most of the the congress, we recommend downloading the event app. We are sure you’ll have a successful event by connecting with other attendees and making sure you don’t miss any session or speakers.
Get the mobile app
Download the app to benefit from all features. Login with the email address you used to register to the event to get access to The Inaugural MedFemTech Congress.
Founding Members
Prof. Zeev Shoham (IVF-Worldwide)
Prof. Milton Leong (IVF-Worldwide)
Prof. Ran Balicer (Chief Innovation Officer, Clalit Health Services, IL)
Mr. Dominique Busso (Forbes)
Ms. Gila Tolub (McKinsey & Company)
Ms. Marie Busson (McKinsey & Company)
Tiffany Starr McKever (Founder and Chief Strategist, Consensus Healthcare Consultants)
Advisory Board
Maura Rosenfeld, MindUP
Marija Butkovic, Women of Wearables
Navneet Kaur, FemTech India
Reenita Das, Frost & Sullivan
Scientific and Medical Board
Prof. Yesha Sivan, DigitalRosh
Itamar Netzer, MD MBA, OB/GYN, Medical Administration specialist, Clalit
Dr. Stasa Stankovic, University of Cambridge
Noemie Elhadad, PhD, Columbia University
Prof. Jennifer Garrison
Prof. Antonio Pellicer, the ‘IVI Foundation’ and ‘Equipo IVI’
Prof. Gerald Schatten, Pittsburgh Development Center
Partners
Founding Partners
Knowledge Partner
Sponsors
Featured Partners
Participants
Contact Us
VENUE
Phone
Industry Liaison
Contact Form
Drop us a line and we’ll get back to you!
The Inaugural MedFemTech Congress
